Bisdemethoxycurcumin attenuates cisplatin-induced renal injury through anti-apoptosis, anti-oxidant and anti-inflammatory
Author:
Funder
National Key R&D Program of China
Science Technology Plan Project of Zhejiang Province
Publisher
Elsevier BV
Subject
Pharmacology
Reference40 articles.
1. Deficient TSC1/TSC2-complex suppression of SOX9-osteopontin-AKT signalling cascade constrains tumour growth in tuberous sclerosis complex;Jin;Hum. Mol. Genet.,2017
2. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?;Aubrey;Cell Death Differ.,2018
3. Cisplatin: a review of toxicities and therapeutic applications;Barabas;Vet. Comp. Oncol.,2008
4. Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis;Chen;Chem. Biol. Interact.,2019
5. Preventive and therapeutic effects of oleuropein against carbon tetrachloride-induced liver damage in mice;Domitrovic;Pharmacol. Res.,2012
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Subjective biosafety assessment of bisdemethoxycurcumin from the rhizomes of Curcuma longa;Toxicology Mechanisms and Methods;2024-03-13
2. Bisdemethoxycurcumin, a curcumin derivative, ameliorates adjuvant-induced arthritis by suppressing inflammatory reactions and macrophage migration;Chemico-Biological Interactions;2024-01
3. IFN-β Pretreatment Alleviates Allogeneic Renal Tubular Epithelial Cell–Induced NK Cell Responses via the IRF7/HLA-E/NKG2A Axis;The Journal of Immunology;2023-12-27
4. Novel bisdemethoxycurcumin@phytomicelle ophthalmic solution: In vitro formulation appraisal and in vivo prompting rapid corneal wound healing evaluations;Experimental Eye Research;2023-09
5. Ocular topical application of alpha-glucosyl hesperidin as an active pharmaceutical excipient: in vitro and in vivo experimental evaluation;Drug Delivery and Translational Research;2023-08-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3